+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

From
From
Trodelvy Patent, Sales & Clinical Trials Insight 2028 - Product Thumbnail Image

Trodelvy Patent, Sales & Clinical Trials Insight 2028

  • Report
  • October 2021
  • 84 Pages
  • Global
From
From
From
From
From
Diabetic Neuropathy Drugs Market 2021-2025 - Product Thumbnail Image

Diabetic Neuropathy Drugs Market 2021-2025

  • Report
  • January 2022
  • 120 Pages
  • Global
From
Antitumor ADC Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Antitumor ADC Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 184 Pages
  • Global
From
From
Antibody Drug Conjugate Market - Global Forecast 2026-2032 - Product Thumbnail Image

Antibody Drug Conjugate Market - Global Forecast 2026-2032

  • Report
  • July 2026
  • 187 Pages
  • Global
From
Stomach Cancer Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Stomach Cancer Treatment Market - Global Forecast 2026-2032

  • Report
  • July 2026
  • 195 Pages
  • Global
From
ROS1 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

ROS1 Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator